Published in J Natl Cancer Inst on January 28, 2010
From differences in means between cases and controls to risk stratification: a business plan for biomarker development. Cancer Discov (2013) 1.49
In 2014, can we do better than CA125 in the early detection of ovarian cancer? World J Biol Chem (2014) 1.04
Intention to seek care for symptoms associated with gynecologic cancers, HealthStyles survey, 2008. Prev Chronic Dis (2011) 0.96
Experience of symptoms indicative of gynaecological cancers in UK women. Br J Cancer (2013) 0.89
In vivo detection of human TRPV6-rich tumors with anti-cancer peptides derived from soricidin. PLoS One (2013) 0.87
Adnexal masses suspected to be benign treated with laparoscopy. JSLS (2012) 0.87
PEGylated liposome IHL-305 markedly improved the survival of ovarian cancer peritoneal metastasis in mouse. BMC Cancer (2012) 0.86
Oophorectomy: the debate between ovarian conservation and elective oophorectomy. Menopause (2013) 0.84
Value of symptom-triggered diagnostic evaluation for ovarian cancer. Obstet Gynecol (2014) 0.82
The utility and cost of routine follow-up procedures in the surveillance of ovarian and primary peritoneal carcinoma: a 16-year institutional review. Br J Cancer (2010) 0.78
Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer. J Clin Invest (2016) 0.78
Utilizing spatial and spectral features of photoacoustic imaging for ovarian cancer detection and diagnosis. J Biomed Opt (2015) 0.77
Variants in the Signaling Protein TSAd are Associated with Susceptibility to Ovarian Cancer in BRCA1/2 Negative High Risk Families. Biomark Insights (2012) 0.76
Symptoms, CA125 and HE4 for the preoperative prediction of ovarian malignancy in Brazilian women with ovarian masses. BMC Cancer (2013) 0.76
A Resident's Perspective of Ovarian Cancer. Diagnostics (Basel) (2017) 0.76
In reply: A large-scale study on the role of ovarian symptom index is necessary. J Gynecol Oncol (2010) 0.75
Re: Predictive value of symptoms for early detection of ovarian cancer. J Natl Cancer Inst (2010) 0.75
An Evaluation of the Applicability of the Risk of Malignancy Index for Adnexal Masses to Patients Seen at a Tertiary Hospital in Chandigarh, India. J Obstet Gynaecol India (2014) 0.75
Effects of Demographics and OTC Analgesics on Ovarian Cancer Symptoms. J Nurse Pract (2013) 0.75
The Association Between Body Mass Index and Presenting Symptoms in African American Women with Ovarian Cancer. J Womens Health (Larchmt) (2016) 0.75
Symptoms Relevant to Surveillance for Ovarian Cancer. Diagnostics (Basel) (2017) 0.75
Complications from Surgeries Related to Ovarian Cancer Screening. Diagnostics (Basel) (2017) 0.75
Re: Predictive value of symptoms for early detection of ovarian cancer. J Natl Cancer Inst (2010) 0.75
Ovarian cancer symptoms speak out--but what are they really saying? J Natl Cancer Inst (2010) 0.75
Quantitative evaluation of an information leaflet to increase prompt help-seeking for gynaecological cancer symptoms. BMC Public Health (2016) 0.75
Diagnostic accuracy of DWI in patients with ovarian cancer: A meta-analysis. Medicine (Baltimore) (2017) 0.75
Prevalence and its associated psychological variables of symptoms of depression and anxiety among ovarian cancer patients in China: a cross-sectional study. Health Qual Life Outcomes (2017) 0.75
Ultrasound Monitoring of Extant Adnexal Masses in the Era of Type 1 and Type 2 Ovarian Cancers: Lessons Learned From Ovarian Cancer Screening Trials. Diagnostics (Basel) (2017) 0.75
A prospective study to evaluate the risk malignancy index and its diagnostic implication in patients with suspected ovarian mass. J Ovarian Res (2017) 0.75
Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol (2004) 6.20
Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer (2007) 4.76
Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. JAMA (2004) 3.81
Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography. BMJ (1993) 3.70
Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial. Am J Obstet Gynecol (2005) 3.25
Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol (2008) 3.22
Ovarian carcinoma diagnosis. Cancer (2000) 3.12
Menopausal hormone therapy and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev (2007) 2.55
Symptoms of ovarian cancer. Obstet Gynecol (2001) 2.27
Early symptoms of ovarian cancer: a case-control study without recall bias. Fam Pract (2005) 1.65
Ovarian cancer: can we make the clinical diagnosis earlier? Cancer (2005) 1.63
Characterization of prediagnostic symptoms among primary epithelial ovarian cancer cases and controls. Gynecol Oncol (2003) 1.55
Symptoms, diagnoses, and time to key diagnostic procedures among older U.S. women with ovarian cancer. Obstet Gynecol (2007) 1.50
Types and duration of symptoms prior to diagnosis of invasive or borderline ovarian tumor. Gynecol Oncol (2001) 1.48
Symptoms and diagnosis of borderline, early and advanced epithelial ovarian cancer. Gynecol Oncol (2004) 1.43
Presenting symptoms of epithelial ovarian cancer. Aust N Z J Obstet Gynaecol (2005) 1.31
Temporal patterns of conditions and symptoms potentially associated with ovarian cancer. J Womens Health (Larchmt) (2007) 1.10
Clinical picture of women with early stage ovarian cancer. Gynecol Oncol (1999) 1.10
Cancer killer may be "silent" no more. J Natl Cancer Inst (2007) 0.96
Differences in symptoms between patients with benign and malignant ovarian neoplasms. Am J Obstet Gynecol (2004) 0.96
Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA (2003) 7.42
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol (2012) 5.70
Potential for conflict of interest in the evaluation of suspected adverse drug reactions: use of cerivastatin and risk of rhabdomyolysis. JAMA (2004) 4.71
Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA (2011) 4.70
Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet (2010) 4.51
Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas. Gastroenterology (2013) 4.43
Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol (2005) 4.04
Outcomes of planned home births in Washington State: 1989-1996. Obstet Gynecol (2002) 3.99
Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology (2002) 3.28
Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study. Lancet (2008) 3.23
Hormone replacement therapy in relation to breast cancer. JAMA (2002) 3.14
Efficacy of breast cancer screening in the community according to risk level. J Natl Cancer Inst (2005) 3.06
Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA (2003) 3.04
The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection. Hepatology (2013) 2.98
Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol (2005) 2.92
Randomized trial of light versus deep sedation on mental health after critical illness. Crit Care Med (2009) 2.83
Risk of HIV-1 in rural Kenya: a comparison of circumcised and uncircumcised men. Epidemiology (2004) 2.82
Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative. Diabetes Care (2008) 2.76
Hypericum perforatum (St John's wort) for attention-deficit/hyperactivity disorder in children and adolescents: a randomized controlled trial. JAMA (2008) 2.76
A comparison between audio computer-assisted self-interviews and clinician interviews for obtaining the sexual history. Sex Transm Dis (2004) 2.62
Menopausal hormone therapy and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev (2007) 2.55
25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis (2007) 2.40
Parathyroidectomy rates among United States dialysis patients: 1990-1999. Kidney Int (2004) 2.37
Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med (2008) 2.33
Recent trials in hypertension: compelling science or commercial speech? JAMA (2006) 2.30
A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injury. Crit Care Med (2011) 2.27
Management guided by brain tissue oxygen monitoring and outcome following severe traumatic brain injury. J Neurosurg (2009) 2.21
Male circumcision in Siaya and Bondo Districts, Kenya: prospective cohort study to assess behavioral disinhibition following circumcision. J Acquir Immune Defic Syndr (2007) 2.21
Incidence of suicide in persons with cancer. J Clin Oncol (2008) 2.21
Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years. Cancer (2003) 2.20
Effect of acute lung injury and acute respiratory distress syndrome on outcome in critically ill trauma patients. Crit Care Med (2004) 2.20
Dietary phosphorus is associated with greater left ventricular mass. Kidney Int (2013) 2.19
Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med (2013) 2.15
Body mass index, weight, and oral contraceptive failure risk. Obstet Gynecol (2005) 2.07
Tradeoffs between accuracy measures for electronic health care data algorithms. J Clin Epidemiol (2011) 2.06
Type I and II endometrial cancers: have they different risk factors? J Clin Oncol (2013) 2.01
Insulin therapy, hyperglycemia, and hypertension in type 1 diabetes mellitus. Arch Intern Med (2008) 2.01
Reporting participation in case-control studies. Epidemiology (2002) 1.99
Iron deficiency and gastrointestinal malignancy: a population-based cohort study. Am J Med (2002) 1.96
Relationship between menopausal hormone therapy and risk of ductal, lobular, and ductal-lobular breast carcinomas. Cancer Epidemiol Biomarkers Prev (2008) 1.88
Limitations of basing screening policies on screening trials: The US Preventive Services Task Force and Prostate Cancer Screening. Med Care (2013) 1.88
Risk of hip fracture among dialysis and renal transplant recipients. JAMA (2002) 1.81
The prevalence of knee pain and symptomatic knee osteoarthritis among veteran traumatic amputees and nonamputees. Arch Phys Med Rehabil (2005) 1.81
Environment or host?: A case-control study of risk factors for Mycobacterium avium complex lung disease. Am J Respir Crit Care Med (2012) 1.78
Incidence of primary urethral carcinoma in the United States. Urology (2006) 1.78
Trends in treatment of advanced epithelial ovarian cancer in the Medicare population. Gynecol Oncol (2011) 1.77
Association between serum uric acid level and chronic liver disease in the United States. Hepatology (2010) 1.76
The incidence of colorectal cancer following a negative screening sigmoidoscopy: implications for screening interval. Gastroenterology (2004) 1.74
New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniors. J Clin Epidemiol (2009) 1.72
Functional outcomes in pediatric severe sepsis: further analysis of the researching severe sepsis and organ dysfunction in children: a global perspective trial. Pediatr Crit Care Med (2013) 1.70
Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis. JAMA (2004) 1.70
Inflammation and endometrial cancer: a hypothesis. Cancer Epidemiol Biomarkers Prev (2005) 1.68
Effectiveness of adjuvanted influenza vaccination in elderly subjects in northern Italy. Am J Epidemiol (2012) 1.68
Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States. Hepatology (2006) 1.65
Long-term use of postmenopausal estrogen and progestin hormone therapies and the risk of endometrial cancer. Am J Obstet Gynecol (2007) 1.65
Toxicology and epidemiology: improving the science with a framework for combining toxicological and epidemiological evidence to establish causal inference. Toxicol Sci (2011) 1.64
Genetic polymorphisms in the catechol estrogen metabolism pathway and breast cancer risk. Cancer Epidemiol Biomarkers Prev (2009) 1.62
Androgen receptor polymorphisms and the incidence of prostate cancer. Cancer Epidemiol Biomarkers Prev (2002) 1.60
Long-term statin use and risk of ductal and lobular breast cancer among women 55 to 74 years of age. Cancer Epidemiol Biomarkers Prev (2013) 1.59
Pregnancy weight gain and risk of neonatal complications: macrosomia, hypoglycemia, and hyperbilirubinemia. Obstet Gynecol (2006) 1.59
An exploration of the periodontitis-cancer association. Ann Epidemiol (2003) 1.59
Myocardial infarction and stroke associated with diuretic based two drug antihypertensive regimens: population based case-control study. BMJ (2010) 1.58
Point: cervical cancer screening guidelines should consider observational data on screening efficacy in older women. Am J Epidemiol (2013) 1.56
Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study. J Am Soc Nephrol (2006) 1.56
Matched-pair cohort methods in traffic crash research. Accid Anal Prev (2003) 1.55
Prostate cancer screening and mortality: a case-control study (United States). Cancer Causes Control (2004) 1.54
Esterified estrogen and conjugated equine estrogen and the risk of incident myocardial infarction and stroke. Arch Intern Med (2006) 1.50
What proportion of failure to complete secondary school in the US population is attributable to adolescent psychiatric disorder? J Behav Health Serv Res (2003) 1.45
Employment status among adult survivors in the Childhood Cancer Survivor Study. Pediatr Blood Cancer (2008) 1.43
Echinacea purpurea for prevention of upper respiratory tract infections in children. J Altern Complement Med (2005) 1.40
Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin. Cancer (2005) 1.38
Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium. Cancer Epidemiol Biomarkers Prev (2009) 1.37
Shortcomings in the clinical evaluation of new drugs: acute myeloid leukemia as paradigm. Blood (2010) 1.33
Breast cancer recurrence risk in relation to antidepressant use after diagnosis. Breast Cancer Res Treat (2007) 1.31
Delivery of cancer screening: how important is the preventive health examination? Arch Intern Med (2007) 1.31
Statin use and risk of community acquired pneumonia in older people: population based case-control study. BMJ (2009) 1.30
HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients. Kidney Int (2002) 1.29
Quality of HIV care provided by non-physician clinicians and physicians in Mozambique: a retrospective cohort study. AIDS (2010) 1.28
The effect of alcohol consumption on the prevalence of iron overload, iron deficiency, and iron deficiency anemia. Gastroenterology (2004) 1.26
Use of opioids or benzodiazepines and risk of pneumonia in older adults: a population-based case-control study. J Am Geriatr Soc (2011) 1.25
Longer term efficacy of a prophylactic monovalent human papillomavirus type 16 vaccine. Vaccine (2009) 1.24
Cardiovascular hospitalizations and mortality among recipients of hematopoietic stem cell transplantation. Ann Intern Med (2011) 1.23
Determinants of use of intermittent preventive treatment of malaria in pregnancy: Jinja, Uganda. PLoS One (2010) 1.23
Body weight and risk of oral contraceptive failure. Obstet Gynecol (2002) 1.21
Body mass index and weight gain prior to pregnancy and risk of gestational diabetes mellitus. Am J Obstet Gynecol (2008) 1.21
The relationship between alcohol use and risk of breast cancer by histology and hormone receptor status among women 65-79 years of age. Cancer Epidemiol Biomarkers Prev (2003) 1.20
Incidence of recurrent pelvic organ prolapse 10 years following primary surgical management: a retrospective cohort study. Int Urogynecol J Pelvic Floor Dysfunct (2008) 1.20
Hormone replacement therapy regimens and breast cancer risk(1). Obstet Gynecol (2002) 1.20
Reproductive and anthropometric factors in relation to the risk of lobular and ductal breast carcinoma among women 65-79 years of age. Int J Cancer (2003) 1.18
Association of marijuana use and the incidence of testicular germ cell tumors. Cancer (2009) 1.18
Increased risk of hip fracture among men with CKD. Am J Kidney Dis (2008) 1.16
Is prostate-specific antigen velocity useful in early detection of prostate cancer? A critical appraisal of the evidence. J Natl Cancer Inst (2007) 1.15